How a Small Cell Lung Cancer Patient is Outliving the Odds

Learn the latest Small Cell Lung Cancer (SCLC) research. Hear from 14-year SCLC patient/advocate for the underdog, Montessa Lee, who took her anger and turned it into advocacy. Listen to lung cancer researcher Dr. Triparna Sen explain how DNA damage repair inhibitors are the “Achilles Heel” of SCLC tumors.

Guests: 

Montessa Lee: educator, lung cancer patient advocate, 14-year SCLC survivor

Dr. Triparna Sen, Memorial Sloan Kettering Cancer Center, New York

 

Show Notes for this episode

Transcript of this episode

 

LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

While raising funds to support lung cancer research, LCFA will raise the public’s awareness and serve as a resource for patients or anyone seeking answers, hope, and access to updated treatment information, scientific investigation, and clinical trials.

You can also join the conversation with LCFA on Facebook, Twitter, and Instagram.